Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution

<p>Abstract</p> <p>Background</p> <p>Flubendazole (FLBZ) is a poor water solubility broad-spectrum BZD methylcarbamate anthelmintic compound. Cyclodextrins (CDs) are usually used to increase aqueous solubility of poor hydrosoluble compounds. The comparative <it>in...

Full description

Bibliographic Details
Main Authors: Ceballos Laura, Moreno Laura, Torrado Juan J, Lanusse Carlos, Alvarez Luis
Format: Article
Language:English
Published: BMC 2012-05-01
Series:BMC Veterinary Research
Online Access:http://www.biomedcentral.com/1746-6148/8/71
id doaj-db6bcc529fc34011a114e2dc7449427a
record_format Article
spelling doaj-db6bcc529fc34011a114e2dc7449427a2020-11-25T00:55:04ZengBMCBMC Veterinary Research1746-61482012-05-01817110.1186/1746-6148-8-71Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solutionCeballos LauraMoreno LauraTorrado Juan JLanusse CarlosAlvarez Luis<p>Abstract</p> <p>Background</p> <p>Flubendazole (FLBZ) is a poor water solubility broad-spectrum BZD methylcarbamate anthelmintic compound. Cyclodextrins (CDs) are usually used to increase aqueous solubility of poor hydrosoluble compounds. The comparative <it>in vitro</it> aqueous solubility of FLBZ and other BZD anthelmintics in the presence of hydroxypropyl-β-cyclodextrin (HPβCD) was evaluated in the current work. Additionally, the comparative pharmacokinetic behaviour of FLBZ (and its metabolites) administered by the intraruminal (i.r.) or intraabomasal (i.a.) routes to sheep as either an aqueous CDs-based solution or a conventional carboximethylcellulose (CMC) suspension was assessed. Drug solubility studies involving albendazole, mebendazole, oxfendazole and FLBZ were performed in an aqueous solution (pH 1.2 or 7.4) with or without HPβCD (10%, w/v). The pharmacokinetic study involved two experiments. Experiment 1: In a crossover study, sheep received either a FLBZ-CDs solution (n = 3) or a FLBZ-CMC suspension (n = 3) by the i.r. route (3.8 mg/kg). The treatment Groups were reversed after a 21-days washout period. Experiment 2: sheep (n = 4) were treated by the i.a. route with the FLBZ-CDs solution (3.8 mg/kg). Plasma and abomasal fluid samples were collected between 0 and 72 h post-treatment. Samples were analysed by HPLC.</p> <p>Results</p> <p>Improvement of FLBZ aqueous solubility due to CDs resulted markedly higher than that observed for mebendazole and albendazole. However, oppositely to what was expected, the absorption-related pharmacokinetic parameters did not show any marked formulation-dependant effect. After the i.a. administration of FLBZ, the AUC and the Tmax of the parent compound were significantly (P < 0.05) reduced, which is consistent with ruminal bypass.</p> <p>Conclusion</p> <p>The administration of FLBZ as a CDs-based solution, does not seem to achieve great practical relevance for parasite control in sheep.</p> http://www.biomedcentral.com/1746-6148/8/71
collection DOAJ
language English
format Article
sources DOAJ
author Ceballos Laura
Moreno Laura
Torrado Juan J
Lanusse Carlos
Alvarez Luis
spellingShingle Ceballos Laura
Moreno Laura
Torrado Juan J
Lanusse Carlos
Alvarez Luis
Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution
BMC Veterinary Research
author_facet Ceballos Laura
Moreno Laura
Torrado Juan J
Lanusse Carlos
Alvarez Luis
author_sort Ceballos Laura
title Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution
title_short Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution
title_full Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution
title_fullStr Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution
title_full_unstemmed Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution
title_sort exploring flubendazole formulations for use in sheep. pharmacokinetic evaluation of a cyclodextrin-based solution
publisher BMC
series BMC Veterinary Research
issn 1746-6148
publishDate 2012-05-01
description <p>Abstract</p> <p>Background</p> <p>Flubendazole (FLBZ) is a poor water solubility broad-spectrum BZD methylcarbamate anthelmintic compound. Cyclodextrins (CDs) are usually used to increase aqueous solubility of poor hydrosoluble compounds. The comparative <it>in vitro</it> aqueous solubility of FLBZ and other BZD anthelmintics in the presence of hydroxypropyl-β-cyclodextrin (HPβCD) was evaluated in the current work. Additionally, the comparative pharmacokinetic behaviour of FLBZ (and its metabolites) administered by the intraruminal (i.r.) or intraabomasal (i.a.) routes to sheep as either an aqueous CDs-based solution or a conventional carboximethylcellulose (CMC) suspension was assessed. Drug solubility studies involving albendazole, mebendazole, oxfendazole and FLBZ were performed in an aqueous solution (pH 1.2 or 7.4) with or without HPβCD (10%, w/v). The pharmacokinetic study involved two experiments. Experiment 1: In a crossover study, sheep received either a FLBZ-CDs solution (n = 3) or a FLBZ-CMC suspension (n = 3) by the i.r. route (3.8 mg/kg). The treatment Groups were reversed after a 21-days washout period. Experiment 2: sheep (n = 4) were treated by the i.a. route with the FLBZ-CDs solution (3.8 mg/kg). Plasma and abomasal fluid samples were collected between 0 and 72 h post-treatment. Samples were analysed by HPLC.</p> <p>Results</p> <p>Improvement of FLBZ aqueous solubility due to CDs resulted markedly higher than that observed for mebendazole and albendazole. However, oppositely to what was expected, the absorption-related pharmacokinetic parameters did not show any marked formulation-dependant effect. After the i.a. administration of FLBZ, the AUC and the Tmax of the parent compound were significantly (P < 0.05) reduced, which is consistent with ruminal bypass.</p> <p>Conclusion</p> <p>The administration of FLBZ as a CDs-based solution, does not seem to achieve great practical relevance for parasite control in sheep.</p>
url http://www.biomedcentral.com/1746-6148/8/71
work_keys_str_mv AT ceballoslaura exploringflubendazoleformulationsforuseinsheeppharmacokineticevaluationofacyclodextrinbasedsolution
AT morenolaura exploringflubendazoleformulationsforuseinsheeppharmacokineticevaluationofacyclodextrinbasedsolution
AT torradojuanj exploringflubendazoleformulationsforuseinsheeppharmacokineticevaluationofacyclodextrinbasedsolution
AT lanussecarlos exploringflubendazoleformulationsforuseinsheeppharmacokineticevaluationofacyclodextrinbasedsolution
AT alvarezluis exploringflubendazoleformulationsforuseinsheeppharmacokineticevaluationofacyclodextrinbasedsolution
_version_ 1725232209590222848